Curetis is a publicly listed commercial stage molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. Curetis’ Unyvero Solution enables rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that can take up to days or weeks with other techniques. Curetis has distribution agreements across Europe, the Middle East and Asia.
Included in Export Interest Directory? Yes
Business Needs: Direct Sales